PDF Version

PDF版本

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sanjeev Narula will join the Company on August 12, 2024 and will serve as Executive Vice President, Chief Financial Officer.

2024年8月7日，纽约（环球通讯社）--专注于中枢神经系统（CNS）疾病治疗药物开发和商业化的生物制药公司Intra Cellular therapeutics，Inc.（纳斯达克：ITCI）今天宣布，Sanjeev Narula将于2024年8月12日加入该公司，并将担任执行副总裁兼首席财务官。

Mr. Narula will report to Dr. Sharon Mates, ITCI’s Chairman and Chief Executive Officer. Lawrence Hineline, who currently serves as Chief Financial Officer, will retire on the same date but will continue to serve as a consultant to the Company for a period of time to ensure a smooth transition..

纳鲁拉先生将向ITCI主席兼首席执行官莎伦·马特斯博士报告。目前担任首席财务官的劳伦斯·海因莱恩（Lawrence Hineline）将在同一天退休，但将继续担任公司的顾问一段时间，以确保平稳过渡。。

“I am excited to welcome Mr. Narula as our Chief Financial Officer. Sanjeev’s extensive strategic, financial and operational experience in large commercial stage pharmaceutical companies make him a tremendous addition to the ITCI leadership team as the Company continues its rapid growth,” said Sharon Mates, Ph.D., Chairman and Chief Executive Officer of Intra-Cellular Therapies, Inc..

Intra Cellular Therapes，Inc.董事长兼首席执行官Sharon Mates博士说：“我很高兴欢迎Narula先生担任我们的首席财务官。Sanjeev在大型商业阶段制药公司拥有丰富的战略、财务和运营经验，随着公司的持续快速发展，他成为ITCI领导团队的重要成员。”。。

Mr. Narula joins ITCI with significant experience as a finance leader in the pharmaceutical industry. He most recently served as the Chief Financial Officer of Viatris which he joined in 2020 when the company was formed through the combination of Mylan and Upjohn, a division of Pfizer. Prior to Viatris, he served as Chief Financial Officer at Upjohn, overseeing finance, procurement and business technology for all functions of the business.

纳鲁拉先生以制药行业财务领导者的丰富经验加入ITCI。他最近担任Viatris的首席财务官，他于2020年加入Viatris，当时该公司由Mylan和辉瑞（Pfizer）旗下的Upjohn合并而成。在加入Viatris之前，他曾担任Upjohn的首席财务官，负责监督公司所有职能的财务、采购和业务技术。

Sanjeev held several other financial leadership positions during his 16 years at Pfizer, including Chief Financial Officer for its Essential Health Business and Chief Financial Officer of the Primary Care Business Unit, the largest commercial division at the time. Previously, Mr. Narula held various financial and operational leadership positions at American Express and Xerox India.

Sanjeev在辉瑞16年期间还担任过其他几个财务领导职位，包括其基本健康业务的首席财务官和当时最大的商业部门初级保健业务部门的首席财务官。此前，纳鲁拉先生曾在美国运通和施乐印度担任过多个财务和运营领导职位。

Sanjeev received his bachelor’s degree in commerce (honors) from Delhi University and his Chartered Accountant degree from The Institute of Chartered Accountants of India. .

桑杰夫获得德里大学商学学士（荣誉）学位和印度特许会计师协会特许会计师学位。。

“I am deeply honored to join the leadership team at Intra-Cellular Therapies as the Company’s Chief Financial Officer and look forward to contributing to ITCI’s growth strategy, as it continues to build on CAPLYTA’s commercial success and advance its exciting pipeline,” said Mr. Narula.

纳鲁拉先生说：“我非常荣幸能作为公司首席财务官加入Intra Cellular Therapes的领导团队，并期待着为ITCI的增长战略做出贡献，因为它将继续在CAPLYTA的商业成功基础上发展，并推进其令人兴奋的渠道。”。

About Intra-Cellular Therapies

关于细胞内疗法

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Intra Cellular Therapeutics是一家基于诺贝尔奖获得者研究的生物制药公司，该研究使我们能够了解治疗如何影响体内细胞的内部工作。该公司利用这种细胞内方法为患有复杂精神病和神经系统疾病的人开发创新疗法。

For more information, please visit www.intracellulartherapies.com..

有关更多信息，请访问www.intracellulartherapies.com。。

Contact:

联系人：

Intra-Cellular Therapies, Inc.Juan Sanchez, M.D. Vice President, Corporate Communications and Investor Relations646-440-9333

Intra Cellular Therapes，Inc.Juan Sanchez，医学博士，公司传播和投资者关系副总裁646-440-9333

Burns McClellan, Inc.Cameron Radinoviccradinovic@burnsmc.com212-213-0006

Burns McClellan，股份有限公司CameronRadinoviccradinovic@burnsmc.com212-213-0006

Source: Intra-Cellular Therapies Inc.

来源：细胞内疗法公司。